Janić, Miodrag <br/><br/>
Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study.  [electronic resource] 

 -  Vascular pharmacology  12 2017 
 - 45-52 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1879-3649 
<br/><br/><label>Standard No.: </label>10.1016/j.vph.2017.09.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--administration & dosage<br/>Animals<br/>Aorta, Thoracic--drug effects<br/>Arginine--analogs & derivatives<br/>Blood Pressure--drug effects<br/>Cholesterol--blood<br/>Coronary Circulation--drug effects<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Fatty Acids, Monounsaturated--administration & dosage<br/>Female<br/>Fluvastatin<br/>Heart--drug effects<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>In Vitro Techniques<br/>Indoles--administration & dosage<br/>Male<br/>Myocardial Reperfusion Injury--blood<br/>Myocardium--metabolism<br/>Nitric Oxide--blood<br/>Nitric Oxide Synthase Type III--genetics<br/>Rats, Wistar<br/>Receptor, Endothelin A--genetics<br/>Time Factors<br/>Valsartan--administration & dosage<br/>Vasodilation--drug effects